5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 16.63▼ | 16.66▼ | 16.66▼ | 16.84▼ | 16.42▲ |
MA10 | 16.66▼ | 16.67▼ | 16.78▼ | 16.64▼ | 16.22▲ |
MA20 | 16.67▼ | 16.80▼ | 16.91▼ | 16.47▲ | 15.80▲ |
MA50 | 16.84▼ | 16.85▼ | 16.73▼ | 16.24▲ | 16.52▲ |
MA100 | 16.87▼ | 16.63▼ | 16.53▲ | 15.84▲ | 16.50▲ |
MA200 | 16.66▼ | 16.46▲ | 16.38▲ | 16.36▲ | 16.00▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | -0.020▼ | -0.059▼ | 0.034▲ | 0.136▲ |
RSI | 25.050▼ | 27.795▼ | 33.499▼ | 54.049▲ | 56.404▲ |
STOCH | 6.944▼ | 18.097▼ | 3.959▼ | 83.341▲ | 86.248▲ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -54.808 | -31.148 |
CCI | -120.880▼ | -95.448 | -82.397 | 31.398 | 162.031▲ |
Tuesday, August 12, 2025 05:45 AM
Q2 2025 Earnings Call Transcript August 11, 2025 Humacyte, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $-0.15. Operator: Good morning, ladies and gentlemen, and ...
|
Tuesday, August 12, 2025 12:35 AM
Despite a net loss, Humacyte Inc (HUMA) sees promising sales growth and strategic advancements in its Symvess product line.
|
Monday, August 11, 2025 07:01 AM
Gain insights from Humacyte's Q2 2025 earnings call, highlighting Symvess' commercial expansion, strategic pricing, pipeline progress, and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 16.73 | 16.79 | 16.57 | 16.57 | 492,284 |
14/08/25 | 17.05 | 17.10 | 16.95 | 16.98 | 529,800 |
13/08/25 | 16.99 | 17.14 | 16.95 | 17.05 | 609,424 |
12/08/25 | 16.78 | 16.91 | 16.73 | 16.90 | 482,900 |
11/08/25 | 16.62 | 16.695 | 16.59 | 16.69 | 450,000 |
08/08/25 | 16.51 | 16.59 | 16.44 | 16.59 | 304,893 |
07/08/25 | 16.46 | 16.5296 | 16.42 | 16.45 | 464,171 |
06/08/25 | 16.40 | 16.46 | 16.36 | 16.46 | 262,609 |
05/08/25 | 16.35 | 16.4268 | 16.34 | 16.37 | 172,775 |
04/08/25 | 16.25 | 16.42 | 16.25 | 16.35 | 453,459 |
|
|
||||
|
|
||||
|
|